Article

jdsupra.com on 2024-05-10 00:55

FDA Releases New Draft Guidance Regarding Clinical Trial Data Monitoring Committees

The U.S. Food & Drug Administration (FDA) released a new proposed draft guidance in February that would change the FDA’s outlook on the engagement ...

Related news

FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials jdsupra.com
FDA Releases Guidance on Data Monitoring Committees for Clinical Trial Management jdsupra.com
Bias
FDA Proposes Rule to Update Clinical Trial Data Monitoring jdsupra.com
Clinical Trials: Consent Process Clarified in New FDA Final Guidance jdsupra.com
FDA Issues Final Guidance on Informed Consent in Clinical Investigations jdsupra.com
How to use a Data Monitoring Committee in clinical trials: FDA invites industry comment jdsupra.com
With Release of New Guidance, FDA Signals It’s Serious About Enforcing Clinical Trial Data Requirements jdsupra.com
The ABCs of DCTs: New FDA Guidance Provides Recommendations for the Conduct of Decentralized Clinical Trials jdsupra.com
FDA issues milestone draft guidance on decentralized clinical trial design & implementation jdsupra.com
FDA offers guidance on clinical trial waivers for investigators at non-U.S. sites jdsupra.com
Germany
New FDA Draft Guidance on Use of Digital Health Technologies in Clinical Trials jdsupra.com
Cures
FDA issues ambitious new draft guidance to promote clinical trial diversity jdsupra.com
Phase 2
FDA Issues Draft Guidance on Use of Electronic Informed Consent in Clinical Trials jdsupra.com
FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices jdsupra.com
FDA Issues Informed Consent Guidance for IRBs, Clinical Investigators, and Sponsors jdsupra.com
FDA Guidance on Diversity Plans in Clinical Trials: What You Need to Know jdsupra.com
United States , United Kingdom
FDA Draft Guidance Regarding Inclusion of Pregnant Women in Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues Guidance for Clinical Trial Sponsors and Investigators Regarding Impact of COVID-19 on Clinical Trials jdsupra.com
California , United States , Switzerland
FDA Issues New Guidance on IRB Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations jdsupra.com
Cures
DOL Provides Guidance Regarding Monitoring Annuity Providers jdsupra.com